Bioenergetic and Reactive Oxygen Species-generating pathway components

Bioenergetic/ROS-generating pathway components refer to a collective group of enzymes and protein complexes, primarily within the mitochondria and cellular membranes, that facilitate energy production and redox signaling (Sies & Jones, 2020). The primary constituents include the mitochondrial electron transport chain (ETC) complexes (I-V) and the NADPH oxidase (NOX) family of enzymes (Lambeth & Neish, 2014). These pathways are fundamental to cellular homeostasis, as the ETC generates the majority of cellular ATP through oxidative phosphorylation, while NOX enzymes produce reactive oxygen species (ROS) that serve as critical signaling molecules (Weinberg & Chandel, 2015). In various diseases, including cancer and neurodegenerative disorders, these pathways are often dysregulated, leading to metabolic reprogramming or excessive oxidative stress that drives pathology (Vasan et al., 2020). Therapeutic strategies targeting these components aim to either disrupt the bioenergetic advantages of diseased cells, such as cancer cells relying on specific ETC complexes, or to modulate ROS levels to prevent oxidative damage in inflammatory conditions (Bedard & Krause, 2007). However, targeting these central metabolic processes requires careful calibration to avoid systemic toxicity and interference with essential cellular functions (Lalau, 2010).

Other names

Mitochondrial respiratory chainElectron transport chainNADPH oxidase systemOxidative phosphorylation systemRedox-signaling complexesBioenergetic pathway

Inhibition of mitochondrial electron transport chain complexes (e.g., Complex I or III) to disrupt ATP production; inhibition of NADPH oxidase (NOX) enzymes to reduce pathological ROS generation; uncoupling of oxidative phosphorylation to increase metabolic rate (Vasan et al., 2020; Lambeth & Neish, 2014).